Trial Profile
Betaferon Regulatory Post-Marketing Surveillance
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Oct 2014
Price :
$35
*
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Sponsors Bayer
- 16 Aug 2012 Additional location [South Korea] identified as reported by ClinicalTrials.gov.
- 16 Aug 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.